24 related articles for article (PubMed ID: 18281816)
1. Effects of Rosuvastatin on Apolipoprotein J in Balloon-Injured Carotid Artery in Rats.
Yang N; Dong B; Yang J; Li Y; Kou L; Liu Y; Qin Q
Arq Bras Cardiol; 2018 Oct; 111(4):562-568. PubMed ID: 30281685
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle drug- and gene-eluting stents for the prevention and treatment of coronary restenosis.
Yin RX; Yang DZ; Wu JZ
Theranostics; 2014; 4(2):175-200. PubMed ID: 24465275
[TBL] [Abstract][Full Text] [Related]
3. Rosuvastatin reduces neointima formation in a rat model of balloon injury.
Preusch MR; Vanakaris A; Bea F; Ieronimakis N; Shimizu T; Konstandin M; Morris-Rosenfeld S; Albrecht C; Kranzhöfer A; Katus HA; Blessing E; Kranzhöfer R
Eur J Med Res; 2010 Nov; 15(11):461-7. PubMed ID: 21159570
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined therapy with ezetimibe plus simvastatin after drug-eluting stent implantation in a porcine coronary restenosis model.
Cho JS; Jeong MH; Sim DS; Hong YJ; Lim KS; Kim JH; Kim HD; Baek JY; Yoon HJ; Her SH; Jin SW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
J Korean Med Sci; 2010 May; 25(5):716-22. PubMed ID: 20436707
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin II and angiotensin II type 1 receptor blockade on neointimal formation after stent implantation.
Groenewegen HC; van der Harst P; Roks AJ; Buikema H; Zijlstra F; van Gilst WH; de Smet BJ
Int J Cardiol; 2008 May; 126(2):209-15. PubMed ID: 17482691
[TBL] [Abstract][Full Text] [Related]
6. Enhanced effect of losartan and rosuvastatin on neointima hyperplasia.
Yi I; Lee JJ; Park JS; Zhang WY; Kim IS; Kim Y; Shin CY; Kim HS; Myung CS
Arch Pharm Res; 2010 Apr; 33(4):593-600. PubMed ID: 20422369
[TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
Kang BY; Mehta JL
J Cardiovasc Pharmacol Ther; 2009 Dec; 14(4):283-91. PubMed ID: 19724024
[TBL] [Abstract][Full Text] [Related]
8. Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Park JK; Mervaala EM; Muller DN; Menne J; Fiebeler A; Luft FC; Haller H
J Hypertens; 2009 Mar; 27(3):599-605. PubMed ID: 19262227
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
Li Y; Wang Q; Zhou J; Xu Q; Chu X; Sun T; Liu X; Cai S
Eur J Pharmacol; 2014 Jan; 723():23-8. PubMed ID: 24333476
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
van der Harst P; Groenewegen HC; Roks AJ; Buikema H; Zijlstra F; van Gilst WH; de Smet BJ
Coron Artery Dis; 2008 Feb; 19(1):47-53. PubMed ID: 18281816
[TBL] [Abstract][Full Text] [Related]
11. How to accelerate the endothelialization of stents.
Ong AT; Aoki J; Kutryk MJ; Serruys PW
Arch Mal Coeur Vaiss; 2005 Feb; 98(2):123-6. PubMed ID: 15787303
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of neointimal formation and hyperplasia in vein grafts by external stent/sheath.
Desai M; Mirzay-Razzaz J; von Delft D; Sarkar S; Hamilton G; Seifalian AM
Vasc Med; 2010 Aug; 15(4):287-97. PubMed ID: 20511293
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
